Literature DB >> 21719996

Niosomes: a controlled and novel drug delivery system.

Rampal Rajera1, Kalpana Nagpal, Shailendra Kumar Singh, Dina Nath Mishra.   

Abstract

During the past decade formulation of vesicles as a tool to improve drug delivery, has created a lot of interest amongst the scientist working in the area of drug delivery systems. Vesicular system such as liposomes, niosomes, transferosomes, pharmacosomes and ethosomes provide an alternative to improve the drug delivery. Niosomes play an important role owing to their nonionic properties, in such drug delivery system. Design and development of novel drug delivery system (NDDS) has two prerequisites. First, it should deliver the drug in accordance with a predetermined rate and second it should release therapeutically effective amount of drug at the site of action. Conventional dosage forms are unable to meet these requisites. Niosomes are essentially non-ionic surfactant based multilamellar or unilamellar vesicles in which an aqueous solution of solute is entirely enclosed by a membrane resulting from the organization of surfactant macromolecules as bilayer. Niosomes are formed on hydration of non-ionic surfactant film which eventually hydrates imbibing or encapsulating the hydrating aqueous solution. The main aim of development of niosomes is to control the release of drug in a sustained way, modification of distribution profile of drug and for targeting the drug to the specific body site. This paper deals with composition, characterization/evaluation, merits, demerits and applications of niosomes.

Mesh:

Substances:

Year:  2011        PMID: 21719996     DOI: 10.1248/bpb.34.945

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  42 in total

1.  Nonionic surfactant vesicles for delivery of RNAi therapeutics.

Authors:  Orapan Paecharoenchai; Lesheng Teng; Bryant C Yung; Lirong Teng; Praneet Opanasopit; Robert J Lee
Journal:  Nanomedicine (Lond)       Date:  2013-11       Impact factor: 5.307

2.  pH-sensitive pHLIP® coated niosomes.

Authors:  Mohan C Pereira; Monica Pianella; Da Wei; Anna Moshnikova; Carlotta Marianecci; Maria Carafa; Oleg A Andreev; Yana K Reshetnyak
Journal:  Mol Membr Biol       Date:  2017-08-09       Impact factor: 2.857

3.  Biomimetic nanovesicle design for cardiac tissue repair.

Authors:  Sruti Bheri; Jessica R Hoffman; Hyun-Ji Park; Michael E Davis
Journal:  Nanomedicine (Lond)       Date:  2020-08-05       Impact factor: 5.307

4.  Vancomycin-eluting niosomes: a new approach to the inhibition of staphylococcal biofilm on abiotic surfaces.

Authors:  Heba S Barakat; Mervat A Kassem; Labiba K El-Khordagui; Nawal M Khalafallah
Journal:  AAPS PharmSciTech       Date:  2014-06-04       Impact factor: 3.246

5.  Azithromycin cationic non-lecithoid nano/microparticles improve bioavailability and targeting efficiency.

Authors:  Meng Zhong; Yue Feng; Hong Liao; Xueyuan Hu; Shengli Wan; Biyue Zhu; Mi Zhang; Huarong Xiong; Yunli Zhou; Jingqing Zhang
Journal:  Pharm Res       Date:  2014-09-11       Impact factor: 4.200

Review 6.  Advances in the design of solid lipid nanoparticles and nanostructured lipid carriers for targeting brain diseases.

Authors:  Christos Tapeinos; Matteo Battaglini; Gianni Ciofani
Journal:  J Control Release       Date:  2017-08-26       Impact factor: 9.776

7.  Assessment of a New Ginsenoside Rh2 Nanoniosomal Formulation for Enhanced Antitumor Efficacy on Prostate Cancer: An in vitro Study.

Authors:  Hadi Zare-Zardini; Ashraf Alemi; Asghar Taheri-Kafrani; Seyed Ahmad Hosseini; Hossein Soltaninejad; Amir Ali Hamidieh; Mojtaba Haghi Karamallah; Majid Farrokhifar; Mohammad Farrokhifar
Journal:  Drug Des Devel Ther       Date:  2020-08-13       Impact factor: 4.162

8.  Evaluation of minor groove binders (MGBs) as novel anti-mycobacterial agents and the effect of using non-ionic surfactant vesicles as a delivery system to improve their efficacy.

Authors:  Lerato Hlaka; Michael-Jon Rosslee; Mumin Ozturk; Santosh Kumar; Suraj P Parihar; Frank Brombacher; Abedawn I Khalaf; Katharine C Carter; Fraser J Scott; Colin J Suckling; Reto Guler
Journal:  J Antimicrob Chemother       Date:  2017-12-01       Impact factor: 5.790

9.  Design and Validation of a Process Based on Cationic Niosomes for Gene Delivery into Novel Urine-Derived Mesenchymal Stem Cells.

Authors:  Yerai Vado; Gustavo Puras; Melania Rosique; Cesar Martin; Jose Luis Pedraz; Shifa Jebari-Benslaiman; Marian M de Pancorbo; Jon Zarate; Guiomar Perez de Nanclares
Journal:  Pharmaceutics       Date:  2021-05-11       Impact factor: 6.321

Review 10.  The Role of Regulatory T Cells in Epicutaneous Immunotherapy for Food Allergy.

Authors:  Guirong Liu; Manman Liu; Junjuan Wang; Yao Mou; Huilian Che
Journal:  Front Immunol       Date:  2021-07-08       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.